{"transactions":[{"id":1043039,"issuer":{"id":75251,"kind":"organization","name":"MidCap Apollo Institutional Private Lending","symbol":"NONE"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75526,"kind":"organization","name":"MIC Capital Management 85 RSC Ltd","position":3,"cik":"0002006022","reported_name":"MIC Capital Management 85 RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares of Beneficial Interest","published_at":"2025-09-11T20:10:10.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":1667108,"price":25.95,"value":43261452.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount reflects beneficial ownership of the Reporting Persons following the purchase of the common shares of beneficial interest (\"Common Shares\") of MidCap Apollo Institutional Private Lending reported herein and does not reflect a subsequent purchase that was previously reported."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities held directly by MIC Capital Management 85 RSC Ltd, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC."}],"balance_after":13788414,"source":{"system":"sec-edgar","filing":"0000950170-25-114223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006758/000095017025114223/ownership.xml","form_type":"4"}},{"id":1078493,"issuer":{"id":75251,"kind":"organization","name":"MidCap Apollo Institutional Private Lending","symbol":"NONE"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75526,"kind":"organization","name":"MIC Capital Management 85 RSC Ltd","position":3,"cik":"0002006022","reported_name":"MIC Capital Management 85 RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common shares of beneficial interest","published_at":"2025-07-31T23:12:38.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":773328,"price":24.16,"value":18683604.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reflects securities held directly by MIC Capital Management 85 RSC Ltd, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC."}],"balance_after":14561742,"source":{"system":"sec-edgar","filing":"0000950170-25-101063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006758/000095017025101063/ownership.xml","form_type":"4"}},{"id":1190011,"issuer":{"id":81482,"kind":"organization","name":"Blue Owl Technology Finance Corp. II","symbol":"NONE"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75526,"kind":"organization","name":"MIC Capital Management 85 RSC Ltd","position":3,"cik":"0002006022","reported_name":"MIC Capital Management 85 RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":81483,"kind":"organization","name":"MIC Capital Management 93 RSC Ltd","position":4,"cik":"0002063187","reported_name":"MIC Capital Management 93 RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-03-27T16:37:26.000Z","date":"2025-03-24","kind":"other","planned":false,"acquired":false,"shares":31965863.918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As of March 24, 2025,  Blue Owl Technology Finance Corp. ( the \"Issuer\"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation (\"OTF II\"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF (\"Merger Sub\"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 (\"Merger Agreement\"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the \"Initial Merger\"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Persons are filing this exit Form 4 to report that it no longer a beneficially owns more than 10% of securities of the Issuer due to the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As of March 24, 2025,  Blue Owl Technology Finance Corp. ( the \"Issuer\"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation (\"OTF II\"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF (\"Merger Sub\"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 (\"Merger Agreement\"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the \"Initial Merger\"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the \"Merger\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"As of March 24, 2025,  Blue Owl Technology Finance Corp. ( the \"Issuer\"), completed a merger by and among the Issuer, Blue Owl Technology Finance Corp. II, a Maryland corporation (\"OTF II\"), Oriole Merger Sub Inc., a Maryland corporation and wholly owned subsidiary of OTF (\"Merger Sub\"), and other parties thereto pursuant to the Agreement and Plan of Merger, dated as of November 12, 2024 (\"Merger Agreement\"). Pursuant to the Merger Agreement, Merger Sub was first merged with and into OTF II, with OTF II as the surviving corporation (the \"Initial Merger\"), and, immediately following the Initial Merger, OTF II was then merged with and into the Issuer, with the Issuer as the surviving company (the Initial Merger and the subsequent merger, collectively, the \"Merger\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Persons are filing this exit Form 4 to report that it no longer a beneficially owns more than 10% of securities of the Issuer due to the Merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-046148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006022/000095017025046148/ownership.xml","form_type":"4"}},{"id":1189665,"issuer":{"id":11600,"kind":"organization","name":"Endeavor Group Holdings, Inc.","symbol":"EDR"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2025-03-27T06:18:38.000Z","date":"2025-03-24","kind":"other","planned":false,"acquired":false,"shares":2232747,"price":27.5,"value":61400542.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 24, 2025, the previously announced acquisition of the Issuer was completed pursuant to the terms of the Agreement and Plan of Merger, dated as of April 2, 2024 (the \"Merger Agreement\"), by and among the Issuer, Wildcat EGH Holdco, L.P., an affiliate of Silver Lake Group, L.L.C., and other parties thereto. At the effective time of the merger (the \"Effective Time\"), each share of the Issuer's common stock outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $27.50 in cash, without interest and subject to applicable withholding taxes, other than with respect to certain shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities held directly by Fifteenth Investment Company LLC, a wholly owned subsidiary of Mamoura Diversified Global Holding PJSC. Mamoura Diversified Global Holding PJSC is a wholly owned subsidiary of Mubadala Investment Company PJSC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-045701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000095017025045701/ownership.xml","form_type":"4"}},{"id":1972762,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-03T16:09:13.000Z","date":"2023-03-02","kind":"purchase","acquired":true,"shares":66822,"price":7.8171,"value":522354.2562,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,985,927 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12985927,"source":{"system":"sec-edgar","filing":"0001839882-23-005947","document":"rxrx-form4_030223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000183988223005947/rxrx-form4_030223.xml","form_type":"4"}},{"id":1979207,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-02T16:05:29.000Z","date":"2023-03-01","kind":"purchase","acquired":true,"shares":48867,"price":7.9416,"value":388082.1672,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,919,105 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12919105,"source":{"system":"sec-edgar","filing":"0001387131-23-002722","document":"rxrx-form4_030123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002722/rxrx-form4_030123.xml","form_type":"4"}},{"id":1983420,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-01T16:06:15.000Z","date":"2023-02-28","kind":"purchase","acquired":true,"shares":815,"price":7.97,"value":6495.55,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of 12,870,238 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12870238,"source":{"system":"sec-edgar","filing":"0001387131-23-002678","document":"rxrx-form4_022823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002678/rxrx-form4_022823.xml","form_type":"4"}},{"id":1986674,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-28T16:14:59.000Z","date":"2023-02-27","kind":"purchase","acquired":true,"shares":52500,"price":7.69,"value":403725.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.57 to $7.81, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,869,423 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12869423,"source":{"system":"sec-edgar","filing":"0001387131-23-002560","document":"rxrx-form4_022723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002560/rxrx-form4_022723.xml","form_type":"4"}},{"id":1990183,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-27T16:06:41.000Z","date":"2023-02-24","kind":"purchase","acquired":true,"shares":109118,"price":7.639,"value":833552.402,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.56 to $7.86, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,816,923 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12816923,"source":{"system":"sec-edgar","filing":"0001839882-23-004972","document":"rxrx-form4_022423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000183988223004972/rxrx-form4_022423.xml","form_type":"4"}},{"id":1992971,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-24T16:08:02.000Z","date":"2023-02-23","kind":"purchase","acquired":true,"shares":51864,"price":7.7856,"value":403792.3584,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.72 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,707,805 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12707805,"source":{"system":"sec-edgar","filing":"0001387131-23-002375","document":"rxrx-form4_022323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002375/rxrx-form4_022323.xml","form_type":"4"}},{"id":1995696,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-23T16:26:03.000Z","date":"2023-02-22","kind":"purchase","acquired":true,"shares":50941,"price":7.8329,"value":399015.7589,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.69 to $7.94, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,655,941 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12655941,"source":{"system":"sec-edgar","filing":"0001387131-23-002324","document":"rxrx-form4_022323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002324/rxrx-form4_022323.xml","form_type":"4"}},{"id":1999577,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-22T16:07:53.000Z","date":"2023-02-21","kind":"purchase","acquired":true,"shares":94418,"price":7.7435,"value":731125.783,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.65 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,605,000 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12605000,"source":{"system":"sec-edgar","filing":"0001387131-23-002285","document":"rxrx-form4_022123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002285/rxrx-form4_022123.xml","form_type":"4"}},{"id":2003291,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-21T16:07:06.000Z","date":"2023-02-17","kind":"purchase","acquired":true,"shares":63382,"price":7.7149,"value":488985.7918,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.58 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,510,582 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12510582,"source":{"system":"sec-edgar","filing":"0001387131-23-002254","document":"rxrx-form4_021723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002254/rxrx-form4_021723.xml","form_type":"4"}},{"id":2007309,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-17T17:27:59.000Z","date":"2023-02-16","kind":"purchase","acquired":true,"shares":42682,"price":7.8966,"value":337042.6812,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,447,200 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is a wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12447200,"source":{"system":"sec-edgar","filing":"0001387131-23-002226","document":"rxrx-form4_021623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123002226/rxrx-form4_021623.xml","form_type":"4"}},{"id":2013429,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-15T16:06:34.000Z","date":"2023-02-14","kind":"purchase","acquired":true,"shares":6300,"price":7.946,"value":50059.8,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,404,518 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12404518,"source":{"system":"sec-edgar","filing":"0001839882-23-003873","document":"rxrx-form4_021323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000183988223003873/rxrx-form4_021323.xml","form_type":"4"}},{"id":2016001,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T16:10:59.000Z","date":"2023-02-13","kind":"purchase","acquired":true,"shares":32474,"price":7.9706,"value":258837.2644,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,398,218 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12398218,"source":{"system":"sec-edgar","filing":"0001839882-23-003743","document":"rxrx-form4_021323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000183988223003743/rxrx-form4_021323.xml","form_type":"4"}},{"id":2019803,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-13T16:41:42.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":11000,"price":7.9825,"value":87807.5,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,365,744 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12365744,"source":{"system":"sec-edgar","filing":"0001387131-23-001898","document":"rxrx-form4_021023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123001898/rxrx-form4_021023.xml","form_type":"4"}},{"id":2035774,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-02T16:07:53.000Z","date":"2023-02-01","kind":"purchase","acquired":true,"shares":600,"price":7.97,"value":4782.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of 12,354,744 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12354744,"source":{"system":"sec-edgar","filing":"0001839882-23-002830","document":"rxrx-form4_020123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000183988223002830/rxrx-form4_020123.xml","form_type":"4"}},{"id":2043610,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-27T16:27:11.000Z","date":"2023-01-26","kind":"purchase","acquired":true,"shares":7886,"price":7.9896,"value":63005.9856,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.95 to $8.00, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,354,144 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12354144,"source":{"system":"sec-edgar","filing":"0001387131-23-000851","document":"rxrx-form4_012623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000851/rxrx-form4_012623.xml","form_type":"4"}},{"id":2044911,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-26T16:11:58.000Z","date":"2023-01-25","kind":"purchase","acquired":true,"shares":24526,"price":7.8801,"value":193267.3326,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchase in multiple transactions at prices ranging from $7.75 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 12,346,258 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12346258,"source":{"system":"sec-edgar","filing":"0001839882-23-001552","document":"rxrx-form4_012523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000183988223001552/rxrx-form4_012523.xml","form_type":"4"}},{"id":2054634,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2023-01-10","kind":"purchase","acquired":true,"shares":69518,"price":7.7224,"value":536845.8032,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $8.00, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12321732,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054633,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2023-01-09","kind":"purchase","acquired":true,"shares":76046,"price":7.638,"value":580839.348,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.43 to $8.00, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12252214,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054632,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2023-01-06","kind":"purchase","acquired":true,"shares":68953,"price":7.4052,"value":510610.7556,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 to $8.00, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12176168,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054631,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2023-01-05","kind":"purchase","acquired":true,"shares":80035,"price":7.3787,"value":590554.2545,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.75, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12107215,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054630,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2023-01-04","kind":"purchase","acquired":true,"shares":91892,"price":7.8013,"value":716877.0596,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $7.88, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12027180,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054629,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":141646,"price":7.5047,"value":1063010.7362,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.37 to $7.83, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":11935288,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054628,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":99754,"price":7.5548,"value":753621.5192,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.33 to $7.72, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":11793642,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054627,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2022-12-29","kind":"purchase","acquired":true,"shares":84622,"price":7.714,"value":652774.108,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.25 to $7.91, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":11693888,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054626,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2022-12-28","kind":"purchase","acquired":true,"shares":71299,"price":7.1796,"value":511898.3004,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":11609266,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054625,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2022-12-27","kind":"purchase","acquired":true,"shares":145652,"price":7.2392,"value":1054403.9584,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.12 to $7.61, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":11537967,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2054624,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-13T16:19:44.000Z","date":"2022-12-23","kind":"purchase","acquired":true,"shares":100378,"price":7.5158,"value":754420.9724,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This is an inadvertent late filing due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.70, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (12) to this Form4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Consists of 12,321,732 shares held of record by Fifteenth Investment Company LLC. Fifteenth Investment Company LLC is wholly owned subsidiary of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":11392315,"source":{"system":"sec-edgar","filing":"0001387131-23-000335","document":"rxrx-form4_011123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713123000335/rxrx-form4_011123.xml","form_type":"4"}},{"id":2129511,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-10-31T16:08:55.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":2551020,"price":9.8,"value":24999996.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 24, 2022, Recursion Pharmaceuticals, Inc. (the \"Issuer\") entered into a securities purchase agreement with Fifteenth Investment Company LLC, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $24,999,996.00, 2,551,020 shares of Class A Common Stock, $0.00001 par value per share (the \"PIPE Shares\") of the Issuer's common stock at a price of $9.80 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of (i) 11,291,937 shares held of record by Fifteenth Investment Company LLC and (ii) 0 shares held of record by Thirty Fifth Investment Company LLC, as a result of a transfer of 5,963,140 shares to Fifteenth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":11291937,"source":{"system":"sec-edgar","filing":"0001387131-22-010982","document":"rxrx-form4_102722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713122010982/rxrx-form4_102722.xml","form_type":"4"}},{"id":2743921,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":5963140,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of (i) 2,777,777 shares held of record by Fifteenth Investment Company LLC and (ii) 5,963,140 shares held of record by Thirty Fifth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5963140},"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743920,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":745392,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock (\"Class A Shares\"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":745392},"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743919,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":2307475,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock (\"Class A Shares\"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2738824},"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743918,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":3578653,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock (\"Class A Shares\"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3578653},"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743917,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":5963140,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of (i) 2,777,777 shares held of record by Fifteenth Investment Company LLC and (ii) 5,963,140 shares held of record by Thirty Fifth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":8740917,"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743916,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-16","kind":"purchase","acquired":true,"shares":2777777,"price":18,"value":49999986.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of (i) 2,777,777 shares held of record by Fifteenth Investment Company LLC and (ii) 5,963,140 shares held of record by Thirty Fifth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On April 16, 2021, Fifteenth Investment Company LLC acquired 2,777,777 Class A Shares at a price of $18 per share in connection with Recursion Pharmaceutical, Inc.'s (the \"Issuer\") initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":2777777,"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743915,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":745392,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock (\"Class A Shares\"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":7062869,"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743914,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":2738824,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock (\"Class A Shares\"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":6317477,"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":2743913,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12299,"kind":"person","name":"Mamoura Diversified Global Holding PJSC","position":2,"cik":"0001419351","reported_name":"Mamoura Diversified Global Holding PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-20T17:06:35.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":3578653,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock (\"Class A Shares\"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":3578653,"source":{"system":"sec-edgar","filing":"0001387131-21-004685","document":"rxrx-form4_041621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419351/000138713121004685/rxrx-form4_041621.xml","form_type":"4"}},{"id":3528175,"issuer":{"id":2726,"kind":"organization","name":"GAIA, INC","symbol":"GAIA"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% holder"}},{"id":157632,"kind":"organization","name":"MDC Capital (Cayman) Ltd","position":2,"cik":"0001763537","reported_name":"MDC Capital (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% holder"}}],"security":"Class A Common Stock","published_at":"2019-05-14T18:24:25.000Z","date":"2019-05-01","kind":"other","acquired":false,"shares":1266461,"price":10.58,"value":13399157.38,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 1, 2019, in connection with fund reorganization activities, the shares previously beneficially owned by the Reporting Persons were contributed to MIC Capital Partners (Public) Parallel Cayman, LP (\"MIC Capital\") in a non-cash transaction at a value of $10.58 per share (the \"Contribution\"). Following the Contribution, the Reporting Persons no longer had beneficial ownership of any shares of the Issuer, but may be considered to have pecuniary interest (without control) in certain shares held by MIC Capital (which such number of shares would be less than 10% of the outstanding class of shares)."},{"field":"shares","element":"transactionShares","label":"F2","text":"1,266,461 shares were held of record by MDC Capital (Cayman) Limited (\"MDC Capital (Cayman)\"), as trustee for Fifty First Investment Company LLC. MDC Capital (Cayman) is a direct wholly owned subsidiary of MDC Capital LLC. MDC Capital LLC, MDC Capital (Cayman) and Fifty First Investment Company LLC are controlled subsidiaries of Mubadala Development Company PJSC. Mubadala Development Company PJSC is wholly owned by Mubadala Investment Company PJSC."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 1, 2019, in connection with fund reorganization activities, the shares previously beneficially owned by the Reporting Persons were contributed to MIC Capital Partners (Public) Parallel Cayman, LP (\"MIC Capital\") in a non-cash transaction at a value of $10.58 per share (the \"Contribution\"). Following the Contribution, the Reporting Persons no longer had beneficial ownership of any shares of the Issuer, but may be considered to have pecuniary interest (without control) in certain shares held by MIC Capital (which such number of shares would be less than 10% of the outstanding class of shares)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On May 1, 2019, in connection with fund reorganization activities, the shares previously beneficially owned by the Reporting Persons were contributed to MIC Capital Partners (Public) Parallel Cayman, LP (\"MIC Capital\") in a non-cash transaction at a value of $10.58 per share (the \"Contribution\"). Following the Contribution, the Reporting Persons no longer had beneficial ownership of any shares of the Issuer, but may be considered to have pecuniary interest (without control) in certain shares held by MIC Capital (which such number of shares would be less than 10% of the outstanding class of shares)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"1,266,461 shares were held of record by MDC Capital (Cayman) Limited (\"MDC Capital (Cayman)\"), as trustee for Fifty First Investment Company LLC. MDC Capital (Cayman) is a direct wholly owned subsidiary of MDC Capital LLC. MDC Capital LLC, MDC Capital (Cayman) and Fifty First Investment Company LLC are controlled subsidiaries of Mubadala Development Company PJSC. Mubadala Development Company PJSC is wholly owned by Mubadala Investment Company PJSC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000947871-19-000369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089872/000094787119000369/ownership.xml","form_type":"4"}},{"id":3528174,"issuer":{"id":2726,"kind":"organization","name":"GAIA, INC","symbol":"GAIA"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% holder"}},{"id":157632,"kind":"organization","name":"MDC Capital (Cayman) Ltd","position":2,"cik":"0001763537","reported_name":"MDC Capital (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% holder"}}],"security":"Class A Common Stock","published_at":"2019-05-14T18:24:25.000Z","date":"2018-12-04","kind":"purchase","acquired":true,"shares":15250,"price":12.74,"value":194285.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person inadvertently failed to report the acquisition of these shares at the time of acquisition."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"1,266,461 shares were held of record by MDC Capital (Cayman) Limited (\"MDC Capital (Cayman)\"), as trustee for Fifty First Investment Company LLC. MDC Capital (Cayman) is a direct wholly owned subsidiary of MDC Capital LLC. MDC Capital LLC, MDC Capital (Cayman) and Fifty First Investment Company LLC are controlled subsidiaries of Mubadala Development Company PJSC. Mubadala Development Company PJSC is wholly owned by Mubadala Investment Company PJSC."}],"balance_after":1266461,"source":{"system":"sec-edgar","filing":"0000947871-19-000369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089872/000094787119000369/ownership.xml","form_type":"4"}},{"id":120428,"issuer":{"id":2796,"kind":"organization","name":"ADVANCED MICRO DEVICES INC","symbol":"AMD"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-02-07T21:29:29.000Z","date":"2019-02-05","kind":"other","acquired":false,"shares":75000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrant was granted to a subsidiary of the Reporting Person as part of the consideration for a commercial agreement between the issuer and such subsidiary and were subsequently transferred to the Reporting Person by such subsidiary (see Exhibit 10.1 of AMD's Current Report on Form 8-K, filed on August 31, 2016)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant became exercisable with respect to 50,000,000 shares of common stock of the issuer upon issuance of the warrant, however did not become exercisable with respect to 25,000,000 shares of common stock of the issuer until August 30, 2017. Exercise of the warrant will be settled with proceeds from the sale of Common Stock detailed in Table I."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates."}],"balance_after":0,"derivative":{"exercise_price":5.98,"exercise_date":"2016-08-30","expiration_date":"2020-02-29","underlying":"Common Stock","underlying_shares":75000000},"source":{"system":"sec-edgar","filing":"0000947871-19-000080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2488/000094787119000080/ownership.xml","form_type":"4"}},{"id":120427,"issuer":{"id":2796,"kind":"organization","name":"ADVANCED MICRO DEVICES INC","symbol":"AMD"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-07T21:29:29.000Z","date":"2019-02-05","kind":"other","acquired":true,"shares":75000000,"price":5.98,"value":448500000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates."}],"balance_after":75000000,"source":{"system":"sec-edgar","filing":"0000947871-19-000080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2488/000094787119000080/ownership.xml","form_type":"4"}},{"id":120426,"issuer":{"id":2796,"kind":"organization","name":"ADVANCED MICRO DEVICES INC","symbol":"AMD"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-07T21:29:29.000Z","date":"2019-02-05","kind":"sale","acquired":false,"shares":34906166,"price":23.43,"value":817851469.38,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000947871-19-000080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2488/000094787119000080/ownership.xml","form_type":"4"}},{"id":126399,"issuer":{"id":2796,"kind":"organization","name":"ADVANCED MICRO DEVICES INC","symbol":"AMD"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T01:36:31.000Z","date":"2018-07-30","kind":"sale","acquired":false,"shares":22000000,"price":19.325,"value":425150000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates."}],"balance_after":109906166,"source":{"system":"sec-edgar","filing":"0000947871-18-000617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2488/000094787118000617/ownership.xml","form_type":"4"}},{"id":138390,"issuer":{"id":2796,"kind":"organization","name":"ADVANCED MICRO DEVICES INC","symbol":"AMD"},"owners":[{"id":12036,"kind":"person","name":"Mubadala Investment Co PJSC","position":1,"cik":"0001704268","reported_name":"Mubadala Investment Co PJSC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-04T21:29:09.000Z","date":"2017-08-04","kind":"sale","acquired":false,"shares":40000000,"price":525600000,"value":2.1024e+16,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held on behalf of the Reporting Person by West Coast Hitech L.P., a Cayman Islands limited partnership wholly-owned and controlled by the Reporting Person. West Coast Hitech G.P., Ltd. is a Cayman Islands corporation wholly-owned and controlled by the Reporting Person that acts as the general partner of West Coast Hitech L.P. The business address of West Coast Hitech L.P. and West Coast Hitech G.P., Ltd. is P.O. Box 45005, Abu Dhabi, United Arab Emirates."}],"balance_after":131906166,"source":{"system":"sec-edgar","filing":"0000947871-17-000614","document":"ss54103_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2488/000094787117000614/ss54103_4.xml","form_type":"4"}}]}